Richard Angell

Richard Angell

University College London

H-index: 24

Europe-United Kingdom

About Richard Angell

Richard Angell, With an exceptional h-index of 24 and a recent h-index of 15 (since 2020), a distinguished researcher at University College London, specializes in the field of drug discovery, translational reserarch, research commercialisation.

His recent articles reflect a diverse array of research interests and contributions to the field:

Structure–activity relationships for the G-quadruplex-targeting experimental drug QN-302 and two analogues probed with comparative transcriptome profiling and molecular modeling

Substituted naphthalene diimides and their use

A small-molecule PI3Kα activator for cardioprotection and neuroregeneration

Regulation of metastasis suppressor NME1 by a key metabolic cofactor coenzyme A

The potent quadruplex-binding compound SOP1812 shows anti-tumor activity in patient-derived in vivo models of pancreatic cancer

Discovery of sisunatovir (RV521), an inhibitor of respiratory syncytial virus fusion

Evasion of a human cytomegalovirus entry inhibitor with potent cysteine reactivity is concomitant with the utilization of a heparan sulfate proteoglycan-independent route of entry

Asymmetrically substituted quadruplex-binding naphthalene diimide showing potent activity in pancreatic cancer models

Richard Angell Information

University

Position

& Cardiff University

Citations(all)

1680

Citations(since 2020)

538

Cited By

1366

hIndex(all)

24

hIndex(since 2020)

15

i10Index(all)

40

i10Index(since 2020)

15

Email

University Profile Page

Google Scholar

Richard Angell Skills & Research Interests

drug discovery

translational reserarch

research commercialisation

Top articles of Richard Angell

Structure–activity relationships for the G-quadruplex-targeting experimental drug QN-302 and two analogues probed with comparative transcriptome profiling and molecular modeling

Scientific Reports

2024/2/11

Substituted naphthalene diimides and their use

2023/7/6

A small-molecule PI3Kα activator for cardioprotection and neuroregeneration

Nature

2023/6/1

Regulation of metastasis suppressor NME1 by a key metabolic cofactor coenzyme A

Redox Biology

2021/8/1

Richard Angell
Richard Angell

H-Index: 10

Ivan Gout
Ivan Gout

H-Index: 25

The potent quadruplex-binding compound SOP1812 shows anti-tumor activity in patient-derived in vivo models of pancreatic cancer

Cancer Research

2022/6/15

Discovery of sisunatovir (RV521), an inhibitor of respiratory syncytial virus fusion

Journal of Medicinal Chemistry

2021/3/17

Evasion of a human cytomegalovirus entry inhibitor with potent cysteine reactivity is concomitant with the utilization of a heparan sulfate proteoglycan-independent route of entry

Journal of Virology

2020/3/17

Asymmetrically substituted quadruplex-binding naphthalene diimide showing potent activity in pancreatic cancer models

ACS Medicinal Chemistry Letters

2020/7/16

Richard Angell
Richard Angell

H-Index: 10

Stephen Neidle
Stephen Neidle

H-Index: 54

Substituted naphthalenediimide compounds bind selectively to two human quadruplex structures with parallel topology

ACS Medicinal Chemistry Letters

2020/3/30

See List of Professors in Richard Angell University(University College London)